Planning and Evaluation Core

规划与评估核心

• 批准号: 8327535
• 负责人: Reynold Enriquez
• 金额: $ 6.05万
• 依托单位: UNIVERSITY OF PUERTO RICO MED SCIENCES
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8327535
• 关键词: Cancer Center; Clinical; Collaborations; Development; Effectiveness; Elements; Evaluation; Evolution; Funding; Goals; Government; Institution; Island; Mission; Monitor; National Cancer Program; Personnel Recruitments; Population; Process; Research; Research Infrastructure; Resources; Tissues; United States National Institutes of Health; Universities; University of Texas M D Anderson Cancer Center; Work; anticancer research; cancer health disparity; operation; programs

7.0 Overview To sustain the high quality of research expected from this Partnership, strict planning and evaluation processes have been implemented to monitor collaboration building, as well as all projects, programs and cores against both the Partnership's mission, goals and objectives, and the mission/goals and objectives of the U54 mechanism itself. It is our intent to utilize Partnership funding for projects and programs to nurture their development, but not to provide long-term support. As a part of building and sustaining excellence, all projects and programs undergo a strenuous review by our internal and external committees (Table 36) and are expected to (and must develop a plan to) apply for external funding from the NIH or an equivalent agency. These planning and evaluation processes are also instrumental in accurately assessing the Partnership's effectiveness towards achieving its immediate (1-3 years) and intermediate (4-5 years) goals (See Section 1.5) of establishing a sustainable research infrastructure (e.g., key personnel recruitment, clinical accrual cores, tissue cores, assigned building space, and further defining programmatic approaches toward the development of the roadmap to obtain cancer center designation) at the UPRCCC. Not to mention, strategically, a strong planning and evaluation process is needed to aid the Partnership in achieving its long-term goal (post-U54 funding) of regaining NCI-designation for the UPRCCC. Although regaining NCI-designation is not a direct goal within the scope of the U54 mechanism, as Pis, we believe that it is imperative for us to not just think in terms of U54 specifics, but to pursue goals beyond the U54. For us, regaining NCI-designation is a positive step towards building a stronger national cancer program aimed at understanding the reasons behind cancer health disparities and their impact on the populations we serve.

7.0概述 为了保持高质量的研究预期从这一伙伴关系，严格的规划和评估程序 已经实施，以监控协作建设以及所有项目、计划和核心， 伙伴关系的使命、目标和目的，以及U 54的使命/目标和目的 机制本身。我们的目的是利用伙伴关系的项目和计划资金，以培养他们的 发展，但不提供长期支持。作为建设和维持卓越的一部分，所有项目 我们的内部和外部委员会（表36）对项目进行了严格的审查， 预期（并且必须制定计划）从NIH或同等机构申请外部资金。 这些规划和评价进程也有助于准确评估伙伴关系的 实现近期（1-3年）和中期（4-5年）目标的有效性（见第1.5节） 建立可持续的研究基础设施（例如，关键人员招聘，临床应计核心， 组织核心，分配的建筑空间，并进一步确定发展的方案方法， 获得癌症中心称号的路线图）。更不用说，在战略上， 需要一个规划和评估过程来帮助伙伴关系实现其长期目标（U 54后 重新获得UPRCCC的NCI-designation。虽然重新获得NCI称号并不是一个直接的 在U 54机制的范围内，作为Pis，我们认为我们必须不仅 我们的目标是超越U 54，但我们的目标是超越U 54。对我们来说，重新获得国家癌症研究所的称号 是朝着建立一个更强大的国家癌症计划迈出的积极一步， 癌症健康差异背后的原因及其对我们服务的人群的影响。